Referral to cancer genetic counseling: Are there stages of readiness?

American Journal of Medical Genetics, Part C: Seminars in Medical Genetics

Volumn 142, Issue 4, 2006, Pages 221-231

  O'Neill, Suzanne M ^a,b   Peters, June A ^c   Vogel, Victor G ^d,e   Feingold, Eleanor ^f   Rubinstein, Wendy S ^a,b  

^a EVANSTON NORTHWESTERN HEALTHCARE   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

^e UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Adherence; Breast cancer; Cancer genetic counseling; Genetic testing; Oncology; Psychology; Referral; Risk assessment; Stages of change; Transtheoretical model

Indexed keywords

ADULT; AGED; ARTICLE; AWARENESS; BREAST CANCER; CANCER CONTROL; CANCER GENETIC COUNSELING; CANCER RISK; CLINICAL ARTICLE; CONCEPTUAL FRAMEWORK; DECISION BALANCE SCORE; FEMALE; GENE MUTATION; GENETIC COUNSELING; GENETIC SCREENING; HEALTH CARE PERSONNEL; HETEROZYGOTE; HUMAN; HUMAN EXPERIMENT; INFORMATION DISSEMINATION; ONCOGENE; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PATIENT COUNSELING; PATIENT DECISION MAKING; PATIENT REFERRAL; PRIORITY JOURNAL; RISK ASSESSMENT; SCORING SYSTEM; STAGE BASED THEORY; THEORETICAL MODEL; TRANSTHEORETICAL MODEL;

ADULT; AGED; AWARENESS; BREAST NEOPLASMS; CARCINOMA; DECISION MAKING; FEMALE; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MIDDLE AGED; NEOPLASMS; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT EDUCATION; REFERRAL AND CONSULTATION; RISK ASSESSMENT;

EID: 33750977826     PISSN: 15524868     EISSN: 15524876     Source Type: Journal    
DOI: 10.1002/ajmg.c.30109     Document Type: Article

References (52)

1. Acheson LS, Wiesner GL, Zyzanski SJ, Goodwin MA, Stange KC. 2000. Family history taking in community family practice: Implications for genetic screening. Genet Med 2:180-185.
2. Adams J, White M. 2005. Why don't stage based activity promotion interventions work? Health Educ Res 20:237-243.
3. Andrykowski MA, Munn RK, Studts JL. 1996. Interest in learning of personal genetic risk for cancer: A general population survey. Prev Med 25:527-536.
4. American Society of Human Genetics. 1994. Statement of the American Society of Human Genetics on genetic testing for breast and ovarian cancer predisposition. Am J Hum Genet 55:i-iv.
5. American Society of Clinical Oncology. 2003. American Society of Clinical Oncology Policy Statement Update: Genetic testing for cancer susceptibility. J Clin Oncol 21:2397-2406.
6. Becker MH, Kaback MM, Rosenstock IM, Ruth MV. 1975. Some influences on public participation in a genetic screening program. J Community Health 1:3-14.
7. Biesecker BB, Ishibe N, Hadley DW, Giambarresi TR, Kase RG, Lerman C, Struewing JP. 2000. Psychosocial factors predicting BRCA1/BRCA2 testing decisions in members of hereditary breast and ovarian cancer families. Am J Med Genet 93:257-263.
8. Bowen DJ, Burke W, McTiernan A, Yasui Y, Andersen MR. 2004. Breast cancer risk counseling improves women's functioning. Patient Educ Couns 53:79-86.
9. Brain K, Gray J, Norman P, Parsons E, Clarke A, Rogers C, Mansel R, Harper P. 2000. Why do women attend familial breast cancer clinics? J Med Genet 37:197-202.
10. Brooks L, Lennard F, Shenton A, Lalloo F, Ambus I, Ardern Jones A, Belk R, Kerr B, Craufurd D, Eeles R, Gareth ED. 2004. BRCA1/2 predictive testing: A study of uptake in two centres. Eur J Hum Genet 12:654-662.
11. Burke W, Daly M, Garber J, Botkin J, Kahn MJ, Lynch P, McTiernan A, Offit K, Perlman J, Petersen G, Thomson E, Varricchio C. 1997. Recommendations for followup care of individuals with an inherited predisposition to cancer. JAMA 277:997-1003.
12. Calzone KA, Stopfer J, Blackwood A, Weber BL. 1997. Establishing a cancer risk evaluation program. Cancer Pract 5:228-233.
13. Cappelli M, Surh L, Humphreys L, Verma S, Logan D, Hunter A, Allanson J. 1999. Psychological and social determinants of women's decisions to undergo genetic counseling and testing for breast cancer. Clin Genet 55:419-430.
14. Carroll JC, Heisey RE, Warner E, Goel V, McCready DR. 1999. Hereditary breast cancer. Psychosocial issues and family physicians' role. Can Fam Physician 45:126-132.
15. Culver J, Burke W, Yasui Y, Durfy S, Press N. 2001. Participation in breast cancer genetic counseling: The influence of educational level, ethnic background, and risk perception. J Genet Couns 10:215-231.
16. de Silva D, Gilbert F, Needham G, Deans H, Turnpenny P, Haites N. 1995. Identification of women at high genetic risk of breast cancer through the National Health Service Breast Screening Programme (NHSBSP). J Med Genet 32:862-866.
17. Emery J, Hayflick S. 2001. The challenge of integrating genetic medicine into primary care. BMJ 322:1027-1030.
18. Frezzo TM, Rubinstein WS, Dunham D, Ormond KE. 2003. The genetic family history as a risk assessment tool in internal medicine. Genet Med 5:84-91.
19. Geer KP, Ropka ME, Cohn WF, Jones SM, Miesfeldt S. 2001. Factors influencing patients' decisions to decline cancer genetic counseling services. J Genet Couns 10: 25-40.
20. Geller G, Doksum T, Bernhardt BA, Metz SA. 1999. Participation in breast cancer susceptibility testing protocols: Influence of recruitment source, altruism, and family involvement on women's decisions. Cancer Epidemiol Biomarkers Prev 8:377-383.
21. Grover S, Stoffel EM, Bussone L, Tschoegl E, Syngal S. 2004. Physician assessment of family cancer history and referral for genetic evaluation in colorectal cancer patients. Clin Gastroenterol Hepatol 2:813-819.
22. Houlihan GD. 1999. The evaluation of the 'stages of change' model for use in counselling client's undergoing predictive testing for Huntingtons disease. J Adv Nurs 29:1137-1143.
23. Jacobsen PB, Valdimarsdottier HB, Brown KL, Offit K. 1997. Decision making about genetic testing among women at familial risk for breast cancer. Psychosom Med 59:459-466.
24. Janis IL, Mann L. 1977. Emergency decision making: A theoretical analysis of responses to disaster warnings. J Human Stress 3:35-45.
25. Julian Reynier C, Eisinger F, Vennin P, Chabal F, Aurran Y, Nogues C, Bignon YJ, Machelard Roumagnac M, Maugard Louboutin C, Serin D, Blanc B, Orsoni P, Sobol H. 1996. Attitudes towards cancer predictive testing and transmission of information to the family. J Med Genet 33:731-736.
26. Lerman C, Seay J, Balshem A, Audrain J. 1995. Interest in genetic testing among first degree relatives of breast cancer patients. Am J Med Genet 57:385-392.
27. Lerman C, Biesecker B, Benkendorf JL, Kerner J, Gomez Caminero A, Hughes C, Reed MM. 1997. Controlled trial of pretest education approaches to enhance informed decision making for BRCA1 gene testing. J Natl Cancer Inst 89:148-157.
28. Littell JH, Girvin H. 2002. Stages of change. A critique Behav Modif 26:223-273.
29. Lynch HT, Lemon SJ, Durham C, Tinley ST, Connolly C, Lynch JF, Surdam J, Orinion E, Slominski Caster S, Watson P, Lerman C, Tonin P, Lenoir G, Serova O, Narod S. 1997. A descriptive study of BRCA1 testing and reactions to disclosure of test results. Cancer 79:2219-2228.
30. Malotte CK, Jarvis B, Fishbein M, Kamb M, Iatesta M, Hoxworth T, Zenilman J, Bolan G. 2000. Stage of change versus an integrated psychosocial theory as a basis for developing effective behaviour change interventions. The Project RESPECT Study Group. AIDS Care 12:357-364.
31. Mouchawar J, Valentine GK, Somkin C, Puleo E, Hensley AS, Geiger AM, Taplin S, Gilbert J, Weinmann S, Zapka J. 2003. Guidelines for breast and ovarian cancer genetic counseling referral: Adoption and implementation in HMOs. Genet Med 5:444-450.
32. O'Neill SM. 2000. Quantitative breast cancer risk assessment. In: Vogel VG, editor. Management of patients at high risk for breast cancer. Malden, MA: Blackwell Science, Inc.
33. Peters JA, Stopfer JE. 1996. Role of the genetic counselor in familial cancer. Oncology (Williston Park) 10:159-166, 175.
34. Prochaska JO, Velicer WF. 1997. The transtheoretical model of health behavior change. Am J Health Promot 12:38-48.
35. Prochaska JO, Velicer WF, Rossi JS, Goldstein MG, Marcus BH, Rakowski W, Fiore C, Harlow LL, Redding CA, Rosenbloom D, et al. 1994. Stages of change and decisional balance for 12 problem behaviors. Health Psychol 13:39-46.
36. Rebbeck TR, Lynch HT, Neuhausen SL, Narod SA, Van't Veer L, Garber JE, Evans G, Isaacs C, Daly MB, Matloff E, Olopade OI, Weber BL. 2002. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N Engl J Med 346:1616-1622.
37. Rebbeck TR, Friebel T, Lynch HT, Neuhausen SL, Van't Veer L, Garber JE, Evans GR, Narod SA, Isaacs C, Matloff E, Daly MB, Olopade OI, Weber BL. 2004. Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: The PROSE Study Group. J Clin Oncol 22:1055-1062.
38. Rose PW, Watson E, Yudkin P, Emery J, Murphy M, Fuller A, Lucassen A. 2001. Referral of patients with a family history of breast/ovarian cancer GPs' knowledge and expectations. Fam Pract 18:487-490.
39. Schneider K. 2002. Counseling about cancer: Strategies for genetic counseling. NY: Wiley Liss. p 167-205.
40. Struewing JP, Lerman C, Kase RG, Giambarresi TR, Tucker MA. 1995. Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families. Cancer Epidemiol Biomarkers Prev 4:169-173.
41. Sweet KM, Bradley TL, Westman JA. 2002. Identification and referral of families at high risk for cancer susceptibility. J Clin Oncol 20:528-537.
42. Trepanier A, Ahrens M, McKinnon W, Peters J, Stopfer J, Grumet SC, Manley S, Culver JO, Acton R, Larsen Haidle J, Correia LA, Bennett R, Pettersen B, Ferlita TD, Costalas JW, Hunt K, Donlon S, Skrzynia C, Farrell C, Callif Daley F, Vockley CW. 2004. Genetic cancer risk assessment and counseling: Recommendations of the national society of genetic counselors. J Genet Couns 13:83-114.
43. Velicer WF, DiClemente CC, Prochaska JO, Brandenburg N. 1985. Decisional balance measure for assessing and predicting smoking status. J Pers Soc Psychol 48:1279-1289.
44. Velicer WF, Norman GJ, Fava JL, Prochaska JO. 1999. Testing 40 predictions from the transtheoretical model. Addict Behav 24: 455-469.
45. Vogel VG. 2001. Reducing the risk of breast cancer with tamoxifen in women at increased risk. J Clin Oncol 19:87-92.
46. Vogel VG, Lo S. 2003. Preventing hormone dependent breast cancer in high risk women. J Natl Cancer Inst 95:91-93.
47. Watson E, Austoker J, Lucassen A. 2001. A study of GP referrals to a family cancer clinic for breast/ovarian cancer. Fam Pract 18:131-134.
48. Weinstein ND. 1988. The precaution adoption process. Health Psychol 7:355-386.
49. Weinstein ND, Rothman AJ, Sutton SR. 1998. Stage theories of health behavior: Conceptual and methodological issues. Health Psychol 17:290-299.
50. Weitzel JN. 1999. Genetic cancer risk assessment. Putting it all together. Cancer 86:2483-2492.
51. Whitelaw S, Baldwin S, Bunton R, Flynn D. 2000. The status of evidence and outcomes in stages of change research. Health Educ Res 15:707-718.
52. Yong MC, Zhou XJ, Lee SC. 2003. The importance of paternal family history in hereditary breast cancer is underappreciated by health care professionals. Oncology 64:220-226.